Salmeterol
Salmeterol        was superior to theophylline (p < or = 0.05) in maintaining nocturnal FEV1 levels       and was superior to placebo (p < or = 0.05) in improving morning and evening peak       expiratory flow (PEF) and in decreasing nighttime albuterol use.
 @SUBJECT$         was superior  @PREDICAT$   @OBJECT$  (p < or = 0.05) in maintaining nocturnal FEV1 levels       and was superior to placebo (p < or = 0.05) in improving morning and evening peak       expiratory flow (PEF) and in decreasing nighttime albuterol use.